Related Experiment Video
Updated: Feb 11, 2026
A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction
Published on: August 27, 2019
To Claim Growth Turf, mTOR Says SOD Off
Hyewon Kong1, Navdeep S Chandel1
1Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Abstract:
Maintaining redox balance in cancer cells is essential for tumor development and progression. In this issue of Molecular Cell, Tsang et al. (2018) identify an evolutionarily conserved mTORC1-dependent mechanism by which cancer cells control redox homeostasis in ischemic tumor microenvironment.
Insights
Cancer cells maintain redox balance using an evolutionarily conserved mechanism dependent on mTORC1 signaling. This process is crucial for survival in the low-oxygen tumor microenvironment.
Area of Science:
- Cellular Biology
- Oncology
- Biochemistry
Background:
- Redox balance is critical for cancer cell survival and tumor progression.
- The tumor microenvironment, particularly ischemic regions, presents unique challenges to cellular homeostasis.
Purpose of the Study:
- To identify mechanisms cancer cells employ to maintain redox balance.
- To investigate the role of mTORC1 signaling in regulating redox homeostasis within the tumor microenvironment.
Main Methods:
- Investigated the role of mechanistic Target of Rapamycin Complex 1 (mTORC1) signaling.
- Studied redox homeostasis in cancer cells under ischemic conditions.
- Utilized an evolutionarily conserved pathway analysis.
Main Results:
- Identified an mTORC1-dependent mechanism for controlling redox homeostasis.
- Demonstrated the importance of this mechanism for cancer cell survival in ischemic conditions.
- Highlighted the evolutionary conservation of this regulatory pathway.
Conclusions:
- The mTORC1-dependent pathway is essential for cancer cells to manage redox balance.
- This mechanism allows cancer cells to adapt and thrive in the challenging, low-oxygen tumor microenvironment.
Related Concept Videos
01:11Testing a Claim about Mean: Known Population SD
Estimating a population mean requires the samples to be distributed normally. The data should be collected from the randomly selected samples having no sampling bias. The sample size needed to be higher than 30, and most importantly, the population standard deviation should be already known.
In most realistic situations, the population standard deviation is often unknown, but in rare circumstances, when it...
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...
01:24Testing a Claim about Population Proportion
There are two methods of testing a claim about a population proportion: (1) Using the sample proportion from the data where a binomial distribution is approximated to the normal distribution and (2) Using the binomial probabilities calculated from the data.
The first method uses normal distribution as an approximation to the binomial distribution. The requirements are as follows: sample size is large...
01:19Testing a Claim about Standard Deviation
The hypothesis testing for the claim of population standard deviation (or variance) requires the data and samples to be random and unbiased. The population distribution also must be normal. There is no specific requirement on the sample size as the estimation is based on the chi-square distribution.
As a first step, the hypothesis (null and alternative) concerning the claim about...
01:21Testing a Claim about Mean: Unknown Population SD
Estimating a population mean requires the samples to be approximately normally distributed. The data should be collected from the randomly selected samples having no sampling bias. There is no specific requirement for sample size. But if the sample size is less than 30, and we don't know the population standard deviation, a different approach is used;...
01:22PI3K/mTOR/AKT Signaling Pathway